1349 fundamentals
SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM earnings per share and revenue
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise